Presidio Management Group VIII L L C

Presidio Management Group VIII L L C discloses dealings in 6 companies, chiefly Maxlinear, Inc, OncoMed Pharmaceuticals Inc and Guidewire Software, Inc. Over a trading history stretching from 31 January 2006 to 8 August 2014, the count stands at 261 filings.

The open-market side counts 14 purchases for €8.1M alongside 77 sales for €153.9M. Netting one side against the other leaves €145.8M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 8 share grants. So far in 2014, the count stands at no purchases and 7 sales.

The median purchase comes to €18k.

Most recently, on 12 August 2014, the filings show a transaction in OncoMed Pharmaceuticals Inc. The last insider purchase was made public on 23 July 2013, 4,841 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.